Alterations of protein expression in serum of infants with intrauterine growth restriction and different gestational ages

Journal of Proteomics

Volumn 119, Issue , 2015, Pages 169-182

  Ruiz, María D ^a   Cañete, María D ^b   Gómez Chaparro, José L ^c   Abril, Nieves ^d   Cañete, Ramón ^e   López Barea, Juan ^d  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b Maimonides Institute for Research in Biomedicine of Cordoba   (Spain)

^c Experimental Unit Córdoba District EUCD AHS   (Spain)

^d UNIVERSITY OF CÓRDOBA   (Spain)

^e Andalusian Health Service   (Spain)

Author keywords

Human newborn; Intrauterine growth restriction; Proteomics; Venous blood serum proteins

Indexed keywords

ACYLTRANSFERASE; ALBUMINOID; ANAPHASE PROMOTING COMPLEX SUBUNIT 2; APOLIPOPROTEIN E; KERATIN TYPE I; LYSOPHOSPHOLIPID; LYSOPHOSPHOLIPID ACYLTRANSFERASE 7; MEMBRANE PROTEIN; SOLUTE CARRIER FAMILY MEMBER 2 FRAGMENT; UNCLASSIFIED DRUG; PLASMA PROTEIN; PROTEOME;

APGAR SCORE; ARTICLE; BIRTH WEIGHT; BLOOD SAMPLING; CLINICAL ARTICLE; DOWN REGULATION; FEMALE; GESTATIONAL AGE; HEAD CIRCUMFERENCE; HUMAN; IMAGE ANALYSIS; INFANT; INTRAUTERINE GROWTH RETARDATION; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION; WESTERN BLOTTING; ADULT; BIOSYNTHESIS; BLOOD; CLINICAL TRIAL; GENE EXPRESSION REGULATION; NEWBORN; PREGNANCY; PROTEOMICS;

ADULT; BLOOD PROTEINS; FEMALE; FETAL GROWTH RETARDATION; GENE EXPRESSION REGULATION; GESTATIONAL AGE; HUMANS; INFANT; INFANT, NEWBORN; MALE; PREGNANCY; PROTEOME; PROTEOMICS;

EID: 84925937811     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2015.02.003     Document Type: Article

References (54)

1. Rogers E., Piecuch R. Neurodevelopmental outcomes of infants who experience intrauterine growth restriction. Neoreviews 2009, 3:100-112.
2. Rosenberg A. The IUGR newborn. Semin Perinatol 2008, 32:219-224.
3. García-Dihins Villanova J., Carceller Beltrán R. Crecimiento intrauterino retardado frente a pequeño para su edad gestacional. An Pediatr (Barc) 2002, 57:582-594.
4. Spanish Society of Gynaecology and Obstetrics (SEGO) (homepage on the internet) Madrid: Crecimiento intrauterino restringido Protocolos Asistenciales de la SEGO en. http://www.sego.es.
5. Hendrix N., Berghella V. Non-placental causes of intrauterine growth restriction. Semin Perinatol 2008, 32:61-65.
6. Pallotto E.K., Kilbride H.W. Perinatal outcome and later implications of intrauterine growth restriction. Clin Obstet Gynecol 2006, 49:257-269.
7. Aucott S.W., Donohue P.K., Northington F.J. Increased morbidity in severe early intrauterine growth restriction. J Perinatol 2004, 24:435-440.
8. Lee P.A., Chernausek S.D., Hokken-Koelega A., Czernichow P., International Small for Gestational Age Advisory Board International Small for Gestational Age Advisory Board Consensus Development Conference Statement: management of short children born small for gestational age, April 24-October 1, 2001. Pediatrics 2003, 111:1253-1261.
9. Ross M.G., Beall M.H. Adult sequelae of intrauterine grow restriction. Semin Perinatol 2008, 32:213-218.
10. Gluckman P.D., Harding J.E. The physiology and pathophysiology of intrauterine growth retardation. Horm Res 1997, 48(Suppl. 1):11-16.
11. Barker D.J., Eriksson J.G., Forsén T., Osmond C. Fetal origins of adult disease: strength of effects and biological basis. Int J Epidemiol 2002, 31:1235-1239.
12. Varvarigou A.A. Intrauterine growth restriction as a potential risk factor for disease onset in adulthood. J Pediatr Endocrinol Metab 2010, 23:215-224.
13. Silver L.E., Decamps P.J., Korst L.M., Platt L.D., Castro L. Intrauterine growth restriction is accompanied by decreased renal volume in the human fetus. Am J Obstet Gynecol 2003, 188:1320-1325.
14. Latini G., De Mitri B., Del Vecchio A., Chitano G., De Felice C., Zetterström R. Foetal growth of kidneys, liver and spleen in intrauterine growth restriction: "programming" causing "metabolic syndrome" in adult age. Acta Paediatr 2004, 93:1635-1639.
15. Rodríguez-Soriano J., Aguirre M., Oliveros R., Vallo A. Long-term renal follow-up of extremely low birth weight infants. Pediatr Nephrol 2005, 20:579-584.
16. Ferrara S.D., Viel G. Functional '-omics' in intrauterine growth restriction: novel insights into child development. Expert Rev Proteomics 2012, 9:355-357.
17. de Boo H.A., Harding J.E. Protein metabolism in preterm infants with particular reference to intrauterine growth restriction. Arch Dis Child Fetal Neonatal Ed 2007, 92:315-319.
18. Wang J., Chen L., Li D., Yin Y., Wang X., Li P., et al. Intrauterine growth restriction affects the proteomes of the small intestine, liver, and skeletal muscle in newborn pigs. J Nutr 2008, 138:60-66.
19. Wang X., Wu W., Lin G., Li D., Wu G., Wang J. Temporal proteomic analysis reveals continuous impairment of intestinal development in neonatal piglets with intrauterine growth restriction. J Proteome Res 2010, 9:924-935.
20. Liu C., Lin G., Wang X., Wang T., Wu G., Li D., et al. Intrauterine growth restriction alters the hepatic proteome in fetal pigs. J Nutr Biochem 2013, 24:954-959.
21. Sparre T., Reusens B., Cherif H., Larsen M.R., Roepstorff P., Fey S.J., et al. Intrauterine programming of fetal islet gene expression in rats-effects of maternal protein restriction during gestation revealed by proteome analysis. Diabetologia 2003, 46:1497-1511.
22. Shen Q., Xu H., Wei L.M., Chen J., Liu H.M., Guo W. A comparative proteomic study nephrogenesis in intrauterine growth restriction. Pediatr Nephrol 2010, 25:1063-1072.
23. Dessì A., Atzori L., Noto A., Visser G.H., Gazzolo D., Zanardo V., et al. Metabolomics in newborns with intrauterine growth retardation (IUGR): urine reveals markers of metabolic syndrome. J Matern Fetal Neonatal Med 2011, 24:35-39.
24. Karamessinis P.M., Malamitsi-Puchner A., Boutsikou T., Makridakis M., Vougas K., Fountoulakis M., et al. Marked defects in the expression and glycosylation of alpha2-HS glycoprotein/fetuin-A in plasma from neonates with intrauterine growth restriction: proteomics screening and potential clinical implications. Mol Cell Proteomics 2008, 7(3):591-599.
25. Cecconi D., Lonardoni F., Favretto D., Cosmi E., Tucci M., Visentin S., et al. Changes in amniotic fluid and umbilical cord serum proteomic profiles of foetuses with intrauterine growth retardation. Electrophoresis 2011, 32:3630-3637.
26. Wölter M., Röwer C., Koy C., Reimer T., Rath W., Pecks U., et al. A proteome signature for intrauterine growth restriction derived from multifactorial analysis of mass-spectrometry-based cord blood serum profiling. Electrophoresis 2012, 33:1881-1893.
27. Pecks U., Kirschner I., Wölter M., Schlembach D., Koy C., Rath W., et al. Mass spectrometric profiling of cord blood serum proteomes to distinguish infants with intrauterine growth restriction from those who are small for gestational age and from control individuals. Transl Res 2014, 164:57-69.
28. Carrascosa A., Ferrández A., Yeste D., García-Dihinx J., Romo A., Copil A., et al. Estudio transversal español de crecimiento 2008. Parte I: valores de peso y longitud en recién nacidos de 26-42 semanas de edad gestacional. An Pediatr (Barc) 2008, 68:544-551.
29. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
30. Vioque-Fernández A., Alves de Almeida E., López-Barea J. Assessment of Doñana National Park contamination in Procambarus clarkii: integration of conventional biomarkers and proteomic approaches. Sci Total Environ 2009, 407:1784-1797.
31. Gurtler A., Kunz N., Gomolka M., Homardt S., Friedl A.A., McDonald K., et al. Stain-free technology as a normalization tool in Western blot analysis. Anal Biochem 2013, 433(2):105-111.
32. Dessì A., Ottonello G., Fanos V. Physiopathology of intrauterine growth retardation: from classic data to metabolomics. J Matern Fetal Neonatal Med 2012, 25(Suppl. 5):13-18.
33. Jara A., Kopchick J.J. Proteomics: a comprehensive approach. An Pediatr (Barc) 2013, 78:137-139.
34. Pecks U., Brieger M., Schieessl B., Bauerschlag D.O., Piroth D., Bruno B., et al. Maternal and fetal cord blood lipids in intrauterine growth restriction. J Perinat Med 2012, 40:287-296.
35. Weinkauf M., Hiddemann W., Dreyling M. Sample pooling in 2-D gel electrophoresis: a new approach to reduce nonspecific expression background. Electrophoresis 2006, 27:4555-4558.
36. Gijon M.A., Riekhof W.R., Zarini S., Murphy R.C., Voelker D.R. Lysophospholipid acyltransferases and arachidonate recycling in human neutrophils. J Biol Chem 2008, 283(44):30235-30245.
37. Lee H.C., Inoue T., Sasaki J., Kubo T., Matsuda S., Nakasaki Y., et al. LPIAT1 regulates arachidonic acid content in phosphatidylinositol and is required for cortical lamination in mice. Mol Biol Cell 2012, 23(24):4689-4700.
38. Di Paolo G., De Camilli P. Phosphoinositides in cell regulation and membrane dynamics. Nature 2006, 443(7112):651-657.
39. Serini S., Piccioni E., Merendino N., Calviello G. Dietary polyunsaturated fatty acids as inducers of apoptosis: implications for cancer. Apoptosis 2009, 14(2):135-152.
40. Theil E.C. Iron, ferritin, and nutrition. Annu Rev Nutr 2004, 24:327-343.
41. Basuli D., Stevens R.G., Torti F.M., Torti S.V. Epidemiological associations between iron and cardiovascular disease and diabetes. Front Pharmacol 2014, 5:117. 10.3389/fphar.2014.00117.
42. Bergman D., Kadner S.S., Cruz M.R., Esterman A.L., Tahery M.M., Young B.K., et al. Synthesis of alpha 1-antichymotrypsin and alpha 1-antitrypsin by human trophoblast. Pediatr Res 1993, 34:312-317.
43. Ritchie R.F., Palomaki G.E., Neveux L.M., Navolotskaia O. Glycoprotein (orosomucoid), alpha-1-antitrypsin, and haptoglobin: a comparison of a large cohort to the world's literature. J Clin Lab Anal 2000, 1:265-270.
44. Engstrom G., Lind P., Hedblad B., Stavenow I., Janzon L., Lindgarde F. Long-term effects of inflammation-sensitive plasma proteins and systolic blood pressure on incidence of stroke. Stroke 2002, 33:2744-2749.
45. Buhimschi I.A., Zhao G., Funal E.F., Harris N., Sasson I.E., Bernstein I.M., et al. Proteomic profiling of urine identifies specific fragments of serpina-1 and albumin as biomarkers of preeclampsia. Am J Obstet Gynecol 2008, 199:551.e1-551.e16.
46. Wasiluk A., Dabrowska M., Jaworski S., Prokopowicz J. The concentration of alpha 1 antitrypsin in the maternal serum after delivery of normal and small for gestational age infants. Z Geburtshilfe Neonatol 2000, 204(6):229-231.
47. Wang X., Lin G., Liu Ch., Feng C., Zhou H., Wang T., et al. Temporal proteomic analysis reveals defects in small-intestinal development of porcine fetuses with intrauterine growth restriction. J Nutr Biochem 2014, 25:785-795.
48. Meas T., Deghmoun S., Chevenne D., Gaborit B., Alessi M.C., Lévy-Marchal C. Plasminogen activator inhibitor type-1 is an independent marker of metabolic disorders in young adults born small for gestational age. J Thromb Haemost 2010, 8:2608-2613.
49. Gill G. SUMO and ubiquitin in the nucleus: different functions, similar mechanisms?. Genes Dev 2004, 18:2046-2059.
50. Saitoh H., Hinchey J. Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3. J Biol Chem 2000, 275:6252-6258.
51. Page N.M., Butlin D.J., Lomthaisong K., Lowry P.J. The human apolipoprotein L gene cluster: identification, classification, and site of distribution. Genomics 2001, 74:71-78.
52. Tsai L-Y., Chen Y-L., Tsou K-I., Mu S-C. The impact of Small for Gestational Age on neonatal outcome among Very Low Birth Weight infants. Pediatrics and Neonatology 2014, 10.1016/j.pedneo.2014.07.007.
53. Regev R.H., Lusky A., Dolfin T., Litmanovitz I., Arnon S., Reichman B., et al. Excess mortality and morbidity among small-for-gestational-age premature infants: a population-based study. J Pediatr 2003, 143:186-191.
54. Ross M.G., Beall M.H. Adult sequelae of intrauterine growth restriction. Semin Perinatol 2008, 32:213-218.